Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Osteoarthritis
•
Primary Care
How do you approach treating hand OA?
Anyone has recommended or has heard of peptide BPC 157 for hand osteoarthritis?
Related Questions
How do you counsel patients with autoimmune disease who are considering platelet-rich plasma injections for a musculoskeletal condition unrelated to their autoimmune disease?
How do you manage patients with severe hand OA (no synovitis on exam, negative serologies) who fail to respond to NSAIDs but respond very well to oral steroids?
What is the appropriate interval to obtain a hydroxychloroquine level after making a dosage adjustment?
Would you stop romosozumab if a patient developed mild asymptomatic hypocalcemia while on treatment?
How would you approach management of a patient who develops squamous cell skin cancer while on abatacept?
How frequently do you monitor for hypocalcemia in patients on romosozumab?
What are some strategies to help teach patients transitioning from pediatric to adult care to become more independent with respect to their care and less dependent on their caregivers?
How do you approach prescribing analgesics for osteoarthritis related pain in patients with comorbidities, particularly given new evidence that even acetaminophen is associated with increased risk of GI complications (bleeding, peptic ulcer disease), heart failure and CKD?
Would you consider PTH analogue in a patient with mildly elevated PTH?
Are there any concerns with live vaccine innoculation and patients who are on denosumab?
